HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Onoue Selected Research

Hiroyuki Onoue Research Topics

Disease

2Gout
04/2016 - 03/2015
2Encephalitis (Encephalitis, Rasmussen)
01/2015 - 01/2015
2Multiple Sclerosis
05/2006 - 02/2005
1Lewy Body Disease (Lewy Body Dementia)
07/2020
1REM Sleep Behavior Disorder
07/2020
1Cryptococcosis
04/2019
1Diabetes Mellitus
04/2016
1Hyperuricemia
03/2015
1Parkinson Disease (Parkinson's Disease)
03/2015
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2015
1Neoplasms (Cancer)
01/2015
1Neuromyelitis Optica (Devic's Disease)
01/2015
1Systemic Scleroderma (Systemic Sclerosis)
01/2015
1Parkinsonian Disorders (Parkinsonism)
01/2015
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2015
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
10/2005
1Prion Diseases (Transmissible Spongiform Encephalopathies)
10/2005
1Torticollis (Wryneck)
01/2004
1Polyradiculoneuropathy (Polyradiculoneuritis)
01/2004
1Fibrosis (Cirrhosis)
04/2002
1Mediastinal Fibrosis
04/2002

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
07/2020 - 10/2005
2Uric Acid (Urate)IBA
04/2016 - 03/2015
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2015 - 01/2015
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
07/2020
1SteroidsIBA
04/2019
1urate transporterIBA
04/2016
1ORALIT (ORS)IBA
04/2016
1CholesterolIBA
04/2016
1Glutamic Acid (Glutamate)FDA Link
04/2016
1Glucose (Dextrose)FDA LinkGeneric
04/2016
1AntioxidantsIBA
03/2015
1anticentromere antibodyIBA
01/2015
1Rituximab (Mabthera)FDA Link
01/2015
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2015
1Pharmaceutical PreparationsIBA
01/2015
1Complementary DNA (cDNA)IBA
05/2006
114-3-3 Proteins (14-3-3 Protein)IBA
10/2005
1Nogo ReceptorsIBA
02/2005
1Type A Botulinum Toxins (Botox)FDA Link
01/2004
1Botulinum Toxins (Botulinum Toxin)IBA
01/2004
1Immunoglobulin G (IgG)IBA
04/2002
1Prednisolone (Predate)FDA LinkGeneric
04/2002
1C-Reactive ProteinIBA
04/2002

Therapy/Procedure

2Therapeutics
01/2015 - 01/2004
1Immunotherapy
01/2015
1Retreatment
01/2015
1Injections
01/2004